Roche and Genentech warn of counterfeit Avastin

02/14/2012 | Reuters · Wall Street Journal, The

Roche Holding and its unit Genentech reported that a fake version of their injectable cancer drug Avastin was found in the U.S. The FDA is investigating and has alerted medical practices about the counterfeit product.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC